- Advanced search
|International Nonproprietary Names|
|Search PubMed clinical trials||sarilumab|
|Search PubMed titles||sarilumab|
|Search PubMed titles/abstracts||sarilumab|
|Sarilumab is a monoclonal antibody directed against the interleukin 6 receptor (IL6R). It is in development as a treatment for rheumatoid arthritis (RA).
Peptide sequence and structural information for this antibody are available from its IMGT/mAb-db record. Peptide sequence BLAST search using the heavy and light chain variable regions of sarilumab provides 100% matches to sequences covered by patent US7582298 , and to the antibody with designation VQ8F11-21.